$HSTM

HEALTHSTREAM INC (HSTM): Results of Operations and Financial Condition

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstre

Original reporting
Published Aug 3, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HSTM
Bullish
high confidence
Mentioned
$HSTM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HSTMBullishHigh
01

Why it matters

Traders can update models immediately using the disclosed Q2 performance and the revised 2026 ranges, and reassess near-term expectations for revenue growth, profitability, and cash generation.

02

Market read

Company-specific earnings and guidance update with explicit financial ranges and a declared quarterly dividend.

03

What to watch

Watch the mix shift between subscription and professional services, and whether higher cloud hosting, royalties, and commissions expenses persist into the back half of 2026.

Relevance 7/10Novelty 9/10Timing: after-hours filing of Q2 results and 2026 guidance update (Aug 3, 2026)

Background

The filing is an SEC 8-K Item 2.02 with Exhibit 99.1 announcing HealthStream’s second quarter 2026 results and providing updated full-year 2026 guidance.

Company-level read

Ticker impact

$HSTMBullishHigh confidence
Context

HealthStream reported Q2 2026 results and updated full-year 2026 guidance, including revenue, net income, and Adjusted EBITDA ranges.

Expected impact

Likely positive bias for the next session and into guidance digestion, with volatility around whether investors focus on subscription growth, margin drivers, or the guidance midpoint.

Evidence & confidence

The filing discloses specific Q2 financials (revenue, operating income, net income, EPS, Adjusted EBITDA) and provides updated 2026 guidance ranges, which are actionable inputs for earnings-model updates.

Market effects

Healthcare clinical workforce technology names may see read-across from HealthStream’s subscription growth and margin trajectory.

Primarily impacts US Nasdaq healthcare IT sentiment; limited direct regional spillover beyond healthcare software/IT.

Low global relevance; the disclosure is company-specific with no stated international regulatory or macro linkage.

Counterpoint

Investors may discount the operating income improvement if it is heavily influenced by sublease income and one-time variable consideration catch-up under ASC 606.

Key entities

  • HealthStream, Inc.

    Nasdaq-listed healthcare technology platform company reporting Q2 2026 results and updating 2026 guidance.

  • Virsys12

    Acquisition referenced as contributing $3.1 million to Q2 2026 revenue growth versus Q2 2025.

  • MissionCare Collective

    Acquisition referenced as contributing to Q2 2026 revenue growth versus Q2 2025.

Related articles

$HAINHighAI 8/10

Hain Celestial (HAIN) Q1 2027 Earnings Call Transcript

Hain Celestial (HAIN) reported Q1 2027 net sales of $263M, down 28% YoY due to divestitures. Organic sales fell 2%, while adjusted gross margin rose to 22.7%. Adjusted EBITDA declined to $19M, and net loss widened to $0.05 per share. The company plans to sell its International business for $323M, focusing on North American operations. Full-year free cash flow improved to $58M, and net debt reduced by $151M. Management expects $16M in annual cost savings and plans to increase marketing investment

$AVOMedAI 8/10

Acquisition Momentum Offset by Profitability Headwinds for Mission Produce (AVO)

Mission Produce (AVO) reported Q3 FY26 adjusted EBITDA of $32.4M, beating expectations. Revenue rose 26% YoY to $450M, driven by avocado supply growth and the Calavo acquisition. However, profitability declined, with adjusted net income down YoY. Q4 adjusted EBITDA is projected at $52M-$55M, incorporating Calavo benefits. Institutional investment remained steady, with 20 hedge funds holding shares.

$SUNBHighAI 8/10

Looking Inside Sunbelt Rentals’ (SUNB) Record Revenues, Debt Discipline, and Uneven Segment Margins

Sunbelt Rentals (SUNB) reported Q1 2027 revenue of $3.115B, up 11.2% YoY, driven by acquisitions and FIFA World Cup demand. Adjusted EPS rose 20.4% to $1.18, and the company declared a $0.30 dividend. While adjusted EBITDA grew 8.7% to $1.315B, margins declined due to higher fuel costs and ancillary revenue growth. The UK segment saw revenue and EBITDA declines. Institutional ownership slightly increased, with Dodge & Cox as the largest shareholder.